Stage 4 RCC is metastatic, with common spread to lungs, bones, liver, brain, and adrenal glands. Understanding IMDC risk is ...
Novel immunotherapies and advances in functional imaging promise to build on the achievements of the past two decades and further improve outcomes for patients with renal cell carcinoma (RCC), said ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
Impact of Funding Source on Long-Term Outcomes in Prostate Cancer: Analysis of a Large Public Database From Sao Paulo, Brazil A retrospective study was conducted involving 689 patients with mRCC ...
The US Food and Drug Administration (FDA) has approved lenvatinib (Lenvima, Eisai), in combination with everolimus, for the treatment of patients with advanced renal cell carcinoma who were previously ...
Xencor's clear cell renal cell carcinoma treatment demonstrated evidence of anti-tumor activity in a phase 1 trial. The treatment XmAb819 had an acceptable safety profile that was generally well ...
Woman's World on MSN
Kidney cancer symptoms are often silent - do you have one of the 'big 3' risk factors?
On the list of medical terms we'd rather never hear, cancer is at the top. But when it comes to fighting it, knowledge is ...
ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...
Renal cell carcinoma is the most common form of kidney cancer. It can take time to fully process a diagnosis and what, ...
Relieving venous congestion using thrombectomy may preserve kidney function in RCC with IVC tumor thrombus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback